It began in August 1976, when a 44-year-old schoolteacher named Mabalo Lokela returned from a trip to northern Zaire with a fever.
Lokela ran the school at the Yambuku mission, a village more than 620 miles from Kinshasa — no electricity, no running water. The nurses at the local hospital diagnosed malaria and gave him a quinine injection.
Standard treatment. And the beginning of something no one in that remote corner of central Africa could have imagined.
The fever broke. Then it came back. On Sept. 1, Lokela returned to the hospital with a high fever and increasing agitation.
Four days later, he was bleeding from every orifice. On Sept. 8, he died — just 14 days after he first fell ill.
What no one yet understood was that inside that small Belgian mission hospital — where five syringes were being reused on patient after patient without sterilization — the virus had already taken hold.
A Package Arrived in Antwerp
Thousands of miles from Yambuku, at the Institute of Tropical Medicine in Antwerp, a pilot for the Belgian airline Sabena delivered a bright blue thermos.
Inside was a blood sample from a Belgian nun who had fallen ill with a mysterious illness in Yambuku. A doctor in Kinshasa had sent it for analysis.
Peter Piot, a 27-year-old scientist fresh out of his training, received the package. One of the two vials had broken in transit, and the blood had mixed with the meltwater.
The initial suspicion was yellow fever. But what Piot found under the electron microscope was something else entirely: a long, twisted filament unlike anything ever seen before. A new virus.
What Happened in Yambuku
The Yambuku Mission Hospital was a small, remote Catholic outpost with no physicians and no laboratory. Four Belgian nuns, a priest, a nurse, and seven Zairian staff members made up the entire medical team.
The hospital treated hundreds of patients a week in a region where malaria, typhoid fever, and other infections were endemic.
The conclusion Piot reached after going into the field was an uncomfortable one.
The epidemic had been inadvertently caused by the hospital’s own nuns, who had been giving vitamin injections to pregnant women without sterilizing the needles and syringes between patients.
The virus Lokela had carried back from the north spread through the very hands trying to heal.
The outbreak infected 318 people and killed 280 — a mortality rate of 88%.
Two Outbreaks, the Same Month
What makes Ebola’s origin so striking is that two simultaneous outbreaks emerged in August 1976.
One occurred in Nzara, in what is now South Sudan. The other struck Yambuku, in what is now the Democratic Republic of Congo.
They were distinct variants of the same pathogen. It’s a coincidence that still unsettles epidemiologists: two different strains emerging simultaneously in separate regions.
The coincidence reinforced the hypothesis that the virus was not new to the forest — that it had been circulating among animals for a long time, waiting for a human to cross its path.
The Name They Chose Before Dawn
With the outbreak contained and the virus identified, the pathogen still needed a name.
The team decided not to name it after Yambuku, unwilling to stigmatize the village forever.
There was a map on the wall. The team leader suggested they name it after the nearest river. It was the Ebola River. Sometime between 3 and 4 in the morning, they had a name.
The map was small and imprecise. Only later did they learn that the nearest river to Yambuku was actually a different one.
But the name held. Ebola. Resonant and strange.
A river in northern Congo that most of the world would never have known existed, had it not been for what happened that August.
The Question That Remains Open
Nearly half a century later, the most fundamental question about Ebola still has no definitive answer: where, exactly, it comes from.
The most widely accepted hypothesis is that fruit bats of the family Pteropodidae serve as the natural reservoir.
Some studies suggest that certain species can carry the virus without becoming ill. Yet no single species has been conclusively confirmed as a reservoir host.
The route of transmission from animals to humans, however, is well documented.
The virus enters human populations through contact with infected wild animals — through hunting, handling sick or dead animals, or butchering bushmeat.
Mabalo Lokela, according to some accounts, bought smoked antelope and monkey meat at a roadside stall during his trip to northern Zaire.
More Than 30 Outbreaks Later
Since 1976, more than 30 outbreaks have been recorded, most of them in Africa.
The most devastating came in 2014, when the Ebola epidemic in West Africa spread far beyond the limits of any previous outbreak and killed more than 11,000 people in Guinea, Sierra Leone, and Liberia.
In May 2026, the World Health Organization declared a new emergency over an outbreak of the Bundibugyo strain in the Democratic Republic of Congo, Uganda, and South Sudan — the same region where Peter Piot fought his first battle against this virus nearly 50 years earlier.
Science, however, has not stood still.
Today there are two approved vaccines against Ebola: Ervebo, developed by Merck, and Zabdeno/Mvabea, a two-dose regimen developed by Janssen. Both are effective against the Zaire strain, the most common and most lethal.
Data show that mortality among unvaccinated patients runs at around 56%, compared with 25% among those who are vaccinated.
The problem is that an approved vaccine exists for only one of the three virus strains responsible for major outbreaks. Vaccines for the Sudan and Bundibugyo strains remain in development.
That gap is especially significant given the active 2026 outbreak — caused by the Bundibugyo strain, for which no approved vaccine yet exists.
Yambuku is still a remote village — without adequate health infrastructure, and without the recognition it deserves for altering the course of medical history.
The Ebola River flows northward, through the forest. And the virus that bears its name — that twisted filament a young Belgian scientist first glimpsed through a microscope in 1976 — remains one of the most lethal pathogens on earth.
To this day, science has yet to solve its most fundamental mystery: where it lives when it is not killing.
